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Abstract Chronic inflammation is an important factor in
colorectal carcinogenesis. However, evidence on the effect
of pro-inflammatory and anti-inflammatory foods and
nutrients is scarce. Moreover, there are few studies focus-
ing on diet–gene interactions on inflammation and colo-
rectal cancer (CRC). This study was designed to investigate
the association between the novel dietary inflammatory
index (DII) and CRC and its potential interaction with
polymorphisms in inflammatory genes. Data from the
Bellvitge Colorectal Cancer Study, a case–control study
(424 cases with incident colorectal cancer and 401 hospi-
tal-based controls), were used. The DII score for each
participant was obtained by multiplying intakes of dietary
components from a validated dietary history questionnaire
by literature-based dietary inflammatory weights that
reflected the inflammatory potential of components. Data
from four important single nucleotide polymorphisms
located in genes thought to be important in inflammation-
associated CRC: i.e., interleukin (IL)-4, IL-6, IL-8, and
peroxisome proliferator-activated receptor-c (PPARG)
were analyzed. A direct association was observed between
DII score and CRC risk (ORQ4 vs. Q1 1.65, 95 % CI
1.05–2.60, and P trend 0.011). A stronger association was
found with colon cancer risk (ORQ4 vs. Q1 2.24, 95 % CI
1.33–3.77, and P trend 0.002) than rectal cancer risk
(ORQ4 vs. Q1 1.12, 95 % CI 0.61–2.06, and P trend 0.37).
DII score was inversely correlated with SNP rs2243250 in
IL-4 among controls, and an interaction was observed with
CRC risk. Neither correlation nor interaction was detected
for other inflammatory genes. Overall, high-DII diets are
associated with increased risk of CRC, particularly for
colon cancer, suggesting that dietary-mediated inflamma-
tion plays an important role in colorectal carcinogenesis.
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Department of Epidemiology and Biostatistics, Arnold School of
Public Health, University of South Carolina, Columbia, SC,
USA
F. Canzian
Genomic Epidemiology Group, German Cancer Research Center
(DKFZ), Heidelberg, Germany
S. Landi
Department of Biology, University of Pisa, Pisa, Italy
M. H. Alonso  V. Moreno (&)
Cancer Prevention and Control Program, Catalan Institute of
Oncology (ICO) and CIBERESP, Barcelona, Spain
e-mail: v.moreno@iconcologia.net
M. H. Alonso  V. Moreno
Bellvitge Biomedical Research Institute (IDIBELL), Barcelona,
Spain
V. Moreno
Department of Clinical Sciences, Faculty of Medicine,
University of Barcelona, Barcelona, Spain
123
Genes Nutr (2015) 10:447
DOI 10.1007/s12263-014-0447-x
Keywords Dietary inflammatory index  Colorectal





DII Dietary inflammatory index
IL Interleukin
OR Odds ratio
PPARG Peroxisome proliferator-activated receptor-c
SNPs Single nucleotide polymorphisms
Introduction
Colorectal cancer (CRC) is the third most frequently
occurring cancer and the fourth most common cause of
death from cancer worldwide (Ferlay et al. 2013). A con-
siderable body of evidence suggests that inflammation
plays a key role in the pathogenesis of CRC by stimulating
angiogenesis, damaging DNA, and chronically stimulating
cell proliferation (Coussens and Werb 2002). Thus, patients
with a history of chronic inflammatory bowel diseases have
an increased risk of developing CRC (Laukoetter et al.
2011), whereas habitual use of nonsteroidal anti-inflam-
matory drugs is associated with a lower CRC risk (Wang
and DuBois 2013). Moreover, circulating inflammatory
biomarkers, such as C-reactive protein (CRP) (Aleksandr-
ova et al. 2010), cytokines, chemokines, and cell adhesion
molecules (McClellan et al. 2012; Song et al. 2013), and
some genes related to pro-inflammation (Landi et al. 2003,
2007) tended to be associated with a higher CRC risk. Diet
plays a crucial role in the etiology of CRC (World
Research Cancer Fund and American Institute for Cancer
Research 2007), although there is little evidence of the pro-
inflammatory and anti-inflammatory effects of the overall
diet on CRC risk (Shivappa et al. 2014a).
The dietary inflammation index (DII) is a literature
review-based score that reflects the potential inflammatory
effects of the diet. It was developed by Cavicchia et al.
(2009) and updated by Shivappa et al. (2014b). In this new
version, nearly 2,000 papers were reviewed and scored.
Forty-five food parameters, including foods, nutrients, and
other bioactive compounds were evaluated based on their
inflammatory effect on some specific inflammatory mark-
ers, such as interleukin (IL)-1, IL-4, IL-6, IL-10, tumor
necrosis factor (TNF)-a, and CRP. The DII has been val-
idated demonstrating its effectiveness in predicting serum
CRP levels in a large longitudinal epidemiological study
(Shivappa et al. 2014c). Previously, we observed that
women with a pro-inflammatory diet (higher DII scores)
had a higher risk of developing CRC in a US-based cohort
study (Shivappa et al. 2014a). Furthermore, higher DII
scores have been linked to asthma (Wood et al. 2014), and
using a modification of the previous DII version (Hebert
et al. 2014), a positive association was observed between
the DII and higher concentrations of glucose metabolism
markers (van Woudenbergh et al. 2013).
The aim of the current study was to investigate the
association between DII and CRC risk, and the potential
interactions with some polymorphisms of inflammatory
genes in a Spanish case–control study.
Subjects and methods
Study design and case ascertainment
The Bellvitge Colorectal Cancer Study is a hospital-based
case–control study designed to investigate the relation-
ships between risk factors of CRC and gene–environment
interactions. The full rationale, methods, and design have
been described previously (Landi et al. 2003). Briefly,
primary CRC cases were recruited at the University
Hospital of Bellvitge, Barcelona (Spain), between January
1996 and December 1998. A total of 523 histologically
confirmed CRC cases were identified, of whom 424 par-
ticipated in the study (81 % participation rate). Controls
were randomly selected from admissions to the same
hospital during this period. To minimize selection bias,
the criterion of inclusion in the control group was a new
disease (not previously diagnosed) for that patient.
Twenty-two percent of controls were admitted for internal
medicine, 19 % for acute surgery, 17 % for urology,
16 % for gastroenterology (hernia, peptic ulcer, and
cholecystitis), 15 % for traumatology, and 11 % for cir-
culatory or respiratory conditions. Controls were fre-
quency-matched to cases by sex and age (±5 years). A
total of 470 controls were approached, of whom 442 were
deemed eligible and 401 agreed to participate in the study
(85 % participation rate). All participants gave written
consent, all procedures were in accordance with the
Ethical standards of the Helsinki Declaration, and the
Ethical Committee of the hospital approved the study
protocol.
Dietary assessment
The participants’ habitual diet in the year previous to
diagnosis was recorded in a personal interview using a
validated Spanish dietary history questionnaire (EPIC
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Group of Spain 1997a, b). Energy, nutrient, and flavo-
noid intakes were estimated from the Spanish food
composition tables used for the European Prospective
Investigation into Cancer and Nutrition study (Slimani
et al. 2007; Zamora-Ros et al. 2013a, b). Questionnaire-
derived dietary information was used to calculate DII
scores for all subjects, as described in detail elsewhere
(Cavicchia et al. 2009; Shivappa et al. 2014b). Briefly,
the dietary data for each study participant were first
linked to the regionally representative global database
that provided a robust estimate of a mean and standard
deviation for each of the food parameters (i.e., foods,
nutrients, and other food components such as flavo-
noids) considered (Shivappa et al. 2014b) to derive a z-
score, by subtracting the ‘‘standard global mean’’ from
the amount reported and dividing this value by the
standard deviation. To minimize the effect of ‘‘right
skewing’’ (a common occurrence with dietary data), this
value was then converted to a centered percentile score
which was then multiplied by the respective food
parameter effect score (derived from a literature review
and scoring of 1,941 articles) to obtain subject’s food
parameter-specific DII score. All of the food parameter-
specific DII scores were then summed to create the
overall DII score for every subject in the study (Sup-
plementary Table 1). A positive score indicates a more
pro-inflammatory diet, while a negative score reflects a
diet that is more anti-inflammatory.
Gene and lifestyle assessment
Cases and controls were interviewed by trained personnel
using structured questionnaires designed to collect infor-
mation on sociodemographic characteristics, medical his-
tory, lifetime smoking habits, leisure- and work-related
physical activity. Anthropometric data were measured, and
a blood sample was taken.
The four selected SNPs of inflammatory genes [IL-4, IL-
6, IL-8, and peroxisome proliferator-activated receptor-c
(PPARG)] were the genes significantly associated with
CRC risk in our previous studies in the main effects or in
the subgroup analyses (Landi et al. 2003, 2007). After
DNA was extracted, genotyping was performed with the
TaqMan technology using the protocol recommended by
the supplier (Applied Biosystems, Foster City, CA, USA).
The order of DNAs from cases and controls was random-
ized on PCR plates in order to ensure that a similar number
of cases and controls were analyzed simultaneously in the
same plate. Reactions were run in 96-well plates on a
Tetrad DNA Engine PCR machine (MJ Research, Wal-
tham, MA, USA) and read in a TaqMan 7900HT sequence
detection system (Applied Biosystems, Foster City, CA,
USA).
Statistical analysis
Characteristics of cases and controls were summarized as
percentages of subjects for categorical variables and means
and standard deviations for continuous variables. Distri-
bution of DII score was assessed by the median (25th and
75th percentiles), because the data were skewed to the
right.
The relationships between CRC risk and DII were
assessed by estimating the odds ratios (OR) and 95 %
confidence intervals (CIs) using an unconditional logistic
regression, because the controls were frequency-matched to
cases. DII score was included in the models as quartiles
(categorically) based on the distributions among controls.
To account for potential confounding and adjust for slight
differences in the distribution of sex between cases and
controls (Table 1), model 1 was adjusted for sex, age (years,
continuous), and total energy intake (kcal/day, continuous).
Model 2 was additionally adjusted for body mass index (kg/
m2, continuous), tobacco consumption (former, current, and
never smoker), level of physical activity (no activity, low,
and high), regular medications (aspirin, nonsteroidal anti-
inflammatory drug, both, and none), and first-degree family
history of CRC (yes, no). Tests for linear trend were per-
formed by assigning the medians of each quartile as scores.
DII score was also analyzed as a continuous variable (one
unit of DII increment). The primary analysis was performed
for all CRC combined; secondary analyses were carried out
for colon and rectal cancers separately. The Wald test was
used to evaluate the association and heterogeneity between
cancer sites.
Diet–gene associations were tested by investigating the
relationships between DII score (continuous) and CRC risk
by SNPs of inflammatory genes using unconditional
logistic regression and adjusting for the same variables as
in model 2. Association between gene polymorphisms and
DII score was assessed only in the control population using
a linear regression model adjusted for covariate as model 2
before to test if genotype frequencies followed Hardy–
Weinberg equilibrium. This association was also assessed
in the complete sample. Partial Pearson correlation coef-
ficients for DII and polymorphisms were derived from the
linear models. Interactions between DII score and gene
polymorphisms in relation to CRC risk were tested using
the likelihood ratio test from logistic regression models
with and without the interaction terms. Case-only analysis,
though more powerful, was not considered because DII
score was associated with some polymorphisms among
controls. We used Bonferroni correction to account for
multiple test and used a P value of 0.0125 (0.05–4) to
indicate statistical significance. All statistical tests were
two-tailed and were performed using the SPSS package
program, version 17.0 (SPSS, Chicago, IL) and the genetic
Genes Nutr (2015) 10:447 Page 3 of 9 447
123
epidemiology web tool SNPstats (http://www.snpstats.net)
(Sole et al. 2006).
Results
A total of 424 CRC patients (265 and 159 with colon and
rectal cancer, respectively) and 401 hospital-based control
subjects were included in the current study. The medians
(25th and 75th percentiles) of DII score were 1.44 (-0.88
and 3.18) and 1.06 (-0.73 and 3.05) for cases and controls,
respectively. Age at recruitment and percentage of women
were higher in the fourth quartile compared with the first
(Table 1). In addition, subjects in the highest quartile ten-
ded to smoke less, particularly in cases, and to be less
physically active. Furthermore, participants in the top
quartile reported the lowest intake of total energy, alcohol,
and fruit and vegetables (per 1,000 kcal).
Table 1 Characteristics of 424
colorectal cancer cases and 401
controls by quartiles of dietary




b First-degree family history of
colorectal cancer
All Q1 Q2 Q3 Q4
Cutoff \-0.73 -0.73 to 1.06 1.07 to 3.05 [3.05
N
Cases 424 112 81 114 117
Controls 401 101 101 98 101
Age (years)a
Cases 66.2 (11.7) 63.8 (10.7) 65.1 (11.5) 67.5 (10.6) 68.0 (13.2)
Controls 65.1 (12.5) 64.1 (11.0) 63.8 (11.9) 64.2 (12.8) 68.2 (13.7)
Men (%)
Cases 60.1 80.4 66.7 57.0 39.3
Controls 51.6 66.3 59.4 49.0 31.7
BMI (kg/m2)a
Cases 25.9 (4.2) 26.5 (3.9) 25.7 (3.8) 26.0 (4.4) 25.3 (4.6)
Controls 27.0 (4.8) 26.9 (4.9) 27.9 (4.3) 27.1 (5.4) 26.0 (4.6)
Current smokers (%)
Cases 17.7 22.3 22.2 14.9 12.8
Controls 14.7 11.9 17.8 16.3 12.9
High physical activity (%)
Cases 51.3 52.7 56.3 52.6 45.3
Controls 51.4 52.5 57.4 48.0 47.5
History of colorectal cancerb (%)
Cases 15.3 17.9 13.6 13.2 16.2
Controls 5.0 8.9 3.0 5.1 3.0
Energy (kcal/day)a
Cases 2,175 (793) 2,713 (860) 2,317 (743) 1,983 (618) 1,748 (563)
Controls 1,969 (678) 2,405 (725) 1,972 (594) 1,929 (630) 1,569 (469)
Alcohol (g/day)a
Cases 12.0 (37.6) 31.8 (64.9) 7.6 (25.3) 15.0 (38.4) 2.1 (14.2)
Controls 9.5 (36.5) 14.4 (49.2) 12.7 (41.7) 8.4 (35.5) 4.9 (20.3)
Fruit and vegetables (g/1,000 kcal day)a
Cases 230 (134) 302 (145) 240 (135) 228 (125) 157 (86)
Controls 274 (160) 364 (174) 299 (154) 245 (134) 190 (119)
Red and processed meat (g/1,000 kcal day)a
Cases 38.3 (21.6) 38.5 (21.2) 42.0 (23.8) 36.5 (21.5) 37.1 (20.4)
Controls 39.5 (22.8) 38.0 (24.8) 42.1 (24.4) 38.9 (19.5) 38.9 (22.3)
Aspirin (%)
Cases 16.3 18.8 17.3 15.8 13.7
Controls 18.7 13.9 18.8 15.3 26.7
NSAID (%)
Cases 5.7 3.6 6.2 5.3 7.7
Controls 14.5 10.9 19.8 12.2 14.9
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In both multivariable logistic models, significant direct
associations were observed between DII score and CRC
risk (ORQ4 vs. Q1 1.65, 95 % CI 1.05–2.60, and P trend
0.011) and colon cancer risk (ORQ4 vs. Q1 2.24, 95 % CI
1.33–3.77, and P trend 0.002), but not with rectal cancer
risk (ORQ4 vs. Q1 1.12, 95 % CI 0.61–2.06, and P trend
0.37) (Table 2). Similar results were found when DII score
was evaluated as a continuous variable. However, no sig-
nificant heterogeneity between colon and rectal cancer risk
was detected (P heterogeneity = 0.19).
In the diet–gene analysis, a significant correlation
between DII score and IL-4 rs2243250 polymorphism
(partial r = -0.34, P = 0.009) was found among the
control group. No significant correlation were observed
with IL-6 (partial r = 0.20, P = 0.06), IL-8 (partial
r = 0.15, P = 0.18), and PPARG (partial r = -0.06,
P = 0.63) polymorphisms. Similar associations were
observed in the complete dataset. A significant interaction
was observed between DII score and IL-4 genotype in
relation to CRC risk. Multivariable logistic models evalu-
ating the association between DII score and CRC risk
stratified by SNP of inflammatory genes are presented in
Table 3. The DII score was not associated with CRC for
individuals homozygous CC for rs2243250 in IL-4, but the
DII score was associated with a significant increased risk of
carriers of the T allele (dominant model) (OR 1.34, 95 %
CI 1.14–1.57). No significant interaction was observed for
IL-6, IL-8, or PPARG.
Discussion
In the present case–control study, a statistically significant
direct association was observed between CRC risk and DII
score in a dose-dependent manner. CRC risk was increased
by 51 and 65 % when participants in the third and the
fourth DII quartile, respectively, were compared with those
in the first quartile. Similar results were previously
observed in the Iowa Women’s Health Study, although the
CRC risk, in this cohort, was only increased by 20 %
(Shivappa et al. 2014a). Despite the limited evidence on the
relationship between overall inflammatory effects of diet
and CRC risk, other epidemiological studies have reported
comparable associations between CRC risk and anti-
inflammatory foods (e.g., fruits and vegetables) (World
Research Cancer Fund and American Institute for Cancer
Research 2007), nutrients (e.g., fiber, selenium, and folate)
(van Duijnhoven et al. 2009), and other bioactive com-
pounds (e.g., flavonoids) (Zamora-Ros et al. 2013b). In
addition, higher circulating CRP and cytokine levels
(inflammatory markers) have been associated with
increased CRC risk in case–control studies, but in cohort
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(Aleksandrova et al. 2010; Song et al. 2013; Wu et al.
2013).
Our results suggest that the association of DII score with
colon cancer risk could be stronger than with rectal cancer
risk, but the interaction was not statistically significant. In
other epidemiological studies, similar associations were
reported for colon and rectal cancer risks with DII score
(Shivappa et al. 2014a), and intakes of fruits and vegeta-
bles, fiber, and flavonoids (World Research Cancer Fund
and American Institute for Cancer Research 2007; Zamora-
Ros et al. 2013b; Murphy et al. 2012). However, for cir-
culating CRP levels, significant associations were observed
only for colon cancer risk (Aleksandrova et al. 2010; Wu
et al. 2013). Although colon and rectal cancers may have
different etiologies (Wei et al. 2004), our study did not
show large differences between colon and rectal cancer in
the effect of inflammation. Lack of statistically significant
findings for rectal cancer may be a result of smaller sample
size for rectal cancer.
In previous reports from our case–control study, SNPs in
the IL-4, IL-6, IL-8, and PPARG genes related to inflam-
mation pathways were associated with CRC risk (8; 9). For
IL-4, the main effect was not statistically significant in the
complete dataset (OR 1.23, 95 % CI 0.81–1.86), but was
significant in the colon cancer subgroup (Landi et al. 2007).
Our results have shown that individuals with a T allele in
the rs2243250 SNP, located in the promoter region of IL-4,
tended to have a lower DII. However, when these
individuals had a high DII, their risk of CRC was signifi-
cantly increased. This effect was not observed in individ-
uals with the more frequent C allele. It is interesting that
this SNP has been associated with diverse diseases related
to inflammation, including cancer. In some studies, the T
allele of this SNP was related to an increased disease risk,
such as liver diseases (Zheng et al. 2013), renal cell cancer
(Zhenzhen et al. 2013), and asthma (Liu et al. 2012). On
the other hand, the T allele of this SNP was associated with
a decrease risk in oral cancer (Zhenzhen et al. 2013) and
myocardial infarct in young people (Paffen et al. 2008). We
hypothesize that, in individuals with the T allele, the
activity of the cytokine IL-4 may be downregulated. In
diets with a low DII, protective effects of the IL-4 pathway
might be compensated by other anti-carcinogenic and anti-
inflammatory pathways. However, in diets with a high DII,
these alternative pathways may be not enough, and there-
fore, the CRC risk was higher than in subjects with the C
allele of this SNP. Further studies evaluating the associa-
tion of inflammatory markers and CRC risk by SNP in
inflammatory genes are needed to confirm our findings.
The first step of colorectal carcinogenesis occurs in an
inflammatory environment wherein infiltrating lympho-
cytes and macrophages raise the level of reactive oxygen
and nitrogen spices and stimulate release of pro-inflam-
matory grown factors, cytokines, and chemokines (Cous-
sens and Werb 2002). Microbiota (Candela et al. 2014) and
a healthy diet (Wang et al. 2012) play an important role in
Table 3 Associations between dietary inflammatory index score (continuous) and colorectal cancer risk by polymorphisms in inflammatory
genes in the Bellvitge Colorectal Cancer Study
Gene Rs number Trivial name Cases Controls OR (95 % CI)a P for interactionb
IL4c rs2243250 -588 C[T 0.004
CC 209 207 1.04 (0.95–1.13)
CT?TT 65 59 1.34 (1.14–1.57)
IL6c rs1800795 174 G[C 0.26
GG 131 143 1.12 (1.01–1.24)
GC?CC 222 163 1.04 (0.96–1.13)
IL8c rs4073 -251 T[A 0.85
TT 114 81 1.11 (0.98–1.25)
TA?AA 230 222 1.09 (1.01–1.19)
PPARGc rs1801282 34 C[G 0.49
CC 305 238 1.09 (1.01–1.17)
CG?GG 46 65 1.03 (0.88–1.20)
IL interleukin, PPARG peroxisome proliferator-activated receptor-c
a Increase in CRC risk for each unit of DII score. Adjusted for sex, age, total energy intake, body mass index, first-degree family history of
colorectal cancer, physical activity, tobacco consumption, and medication use (aspirin and nonsteroidal anti-inflammatory drug)
b Differences in risk associated to dietary inflammatory index score by genotype
c Not available data for some individuals produce OR estimates different from the complete dataset shown in Table 2 (OR 1.08, 95 % CI
1.01–1.15). Missing values for IL-4: 150 cases and 135 controls, for IL-6: 71 cases and 95 controls, for IL-8: 80 cases and 98 controls, and for
PPARG: 72 cases and 98 controls
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keeping intestinal mucosa in a state of low-grade inflam-
mation. However, when this is chronically activated, the
inflammatory/oxidative environment becomes a relentless
cycle that results in genetic and pathological damage. All
food components included in the DII score have been
inversely or positively associated with inflammation
(Shivappa et al. 2014b), and therefore, their inclusion in a
dietary score is crucial to properly evaluate the complex
association between diet-related inflammation and CRC
risk.
We are aware that in any case–control study, there are
potential limitations such as reverse-causality and that the
use of hospital controls is not ideal, though there is some
evidence that hospital controls may be superior to popu-
lation controls (especially, when the base population is
difficult to delineate) (Infante-Rivard 2003). Firstly, we
tried to minimize measurement error by using validated
questionnaires administered by trained interviewers (EPIC
Group of Spain 1997a, b). Despite that, intakes of some
dietary components, which were included in the previously
published DII (Shivappa et al. 2014b), such as caffeine,
eugenol, ginger, saffron, selenium, pepper, thyme,oregano,
and rosemary, could not be calculated from our dietary
history. However, the variation in intakes of those specific
dietary components was expected to be low in a mostly
non-vegetarian Spanish population. Secondly, although
extensive information about potential confounders was
available, residual confounding might have remained
because potential confounders could have been measured
with error. Thirdly, the use of hospital controls may have
resulted in a selected control group with potentially dif-
ferent prevalence of inflammatory alleles than the reference
population. However, it has previously shown that hospital
controls have minimal effect on the allele frequencies
(Garte et al. 2001).
In conclusion, we found that high-DII diets are associ-
ated with increased risk of CRC in a hospital-based case–
control study in Spain, which was more pronounced for
colon cancer than for rectal cancer. The positive associa-
tion differed according to the genotype of rs2243250 in the
promoter region of the inflammatory gene IL-4. Future
studies are needed to evaluate the potential use of DII as a
global measure of inflammatory potential of diet in relation
to CRC risk in prospective studies and its relation to
genetic susceptibility.
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González CA (2013a) Differences in dietary intakes, food
sources, and determinants of total flavonoids between Mediter-
ranean and non-Mediterranean countries participating in the
447 Page 8 of 9 Genes Nutr (2015) 10:447
123
European prospective investigation into cancer and nutrition
(EPIC) study. Br J Nutr 109(8):1498–1507. doi:10.1017/S00071
14512003273
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